Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2025-12-26 @ 3:18 AM
NCT ID: NCT05425420
Description: None
Frequency Threshold: 0
Time Frame: Up to 96 hours (4 days)
Study: NCT05425420
Study Brief: Single Dose IV Methadone for Post-Op Pain
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Open Label Methadone IV All participants will be treated with Methadone Hydrochloride IV (over 10 minutes) and monitored overnight. Methadone hydrochloride 0.1mg/kg: Single dose of methadone hydrochloride administered via intravenous (IV) 0 None 0 22 10 22 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (26.0) View
Blood pressure diastolic abnormal SYSTEMATIC_ASSESSMENT Investigations MedDRA (26.0) View
Blood pressure increased SYSTEMATIC_ASSESSMENT Investigations MedDRA (26.0) View
Electrocardiogram QT prolonged SYSTEMATIC_ASSESSMENT Investigations MedDRA (26.0) View
Injection site pain SYSTEMATIC_ASSESSMENT General disorders MedDRA (26.0) View
COVID-19 SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (26.0) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (26.0) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (26.0) View